October 30, 2025 a 06:01 pm

IDXX: Fundamental Ratio Analysis - IDEXX Laboratories, Inc.

Overview of IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc. operates in the healthcare sector with a focus on diagnostics and testing services for animals and water quality. With a solid market position and diversified portfolio, IDEXX holds promising growth potential. The company’s operational emphasis across multiple specialized segments enhances its long-term financial outlook.

Fundamentals Rating

The fundamental analysis of IDEXX Laboratories shows a stable outlook, with some areas to watch for improvement.

Category Score Visualization
Discounted Cash Flow 3
Return on Equity 5
Return on Assets 5
Debt to Equity 1
Price to Earnings 1
Price to Book 1

Historical Rating

The historical fundamentals reveal consistency over time, highlighting stable financial management.

Date Overall DCF ROE ROA D/E P/E P/B
2025-10-30 3 3 5 5 1 1 1
Previous 0 3 5 5 1 1 1

Analyst Price Targets

Analysts suggest a bullish trend for IDEXX with strong potential for price growth.

High Low Median Consensus
$785 $640 $721 $716.75
Stock price chart for IDEXX Laboratories, Inc.

Analyst Sentiment

The analyst sentiment showcases a predominantly positive outlook with a strong inclination towards buying.

Recommendation Count Visualization
Strong Buy 0
Buy 11
Hold 8
Sell 1
Strong Sell 0

Conclusion

IDEXX Laboratories, Inc. holds a solid position in the diagnostics market, underpinned by robust returns and innovative product offerings. Analyst targets suggest further stock growth potential, though a closer watch on debt-to-equity ratios is advisable. The lack of strong sell recommendations reflects positive market sentiment, signaling investor confidence. Yet, the price multiples suggest a need for cautious valuation. Overall, with growth prospects in place, IDEXX remains a promising investment avenue in a dynamic healthcare market.